Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:ABBV
AbbVie
|
164.25 | -22% | -11.68% | 290,828.77 | 3.81% | 7.24% |
|
NasdaqGS:AMGN
Amgen
|
264.07 | 3.82% | 14.24% | 141,520.1 | 3.39% | 5.31% |
|
NasdaqGM:ALXN
Alexion Pharmaceuticals
|
182.50 | 0% | 0% | 40,336.01 | 0% | 0% |
|
NasdaqGS:BIIB
Biogen
|
192.16 | 1.72% | 19.77% | 27,932.53 | 0% | -10.89% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
90.47 | 116.92% | 188.06% | 17,168.95 | 0% | 32.46% |
|
NasdaqGS:INCY
Incyte
|
52.72 | 107.33% | 156.4% | 11,837.02 | 0% | 27.98% |
|
NasdaqGS:EXEL
Exelixis
|
22.87 | 46.59% | 78.45% | 6,209.42 | 0% | -9.46% |
|
NasdaqGM:ARNA
Arena Pharmaceuticals
|
99.99 | 0% | 0% | 6,165.32 | 0% | 0% |
|
NasdaqGS:BPMC
Blueprint Medicines
|
88.38 | 0% | 0% | 5,526.83 | 0% | 0% |
|
NasdaqGM:IOVA
Iovance Biotherapeutics
|
11.80 | 0% | 0% | 4,861.79 | 0% | 0% |
|
NasdaqGS:ACAD
ACADIA Pharmaceuticals
|
17.19 | 0% | 0% | 4,327.79 | 0% | 0% |
|
NasdaqGM:FOLD
Amicus Therapeutics
|
10.55 | 0% | 0% | 3,797.68 | 0% | 0% |
|
NasdaqGS:CCXI
ChemoCentryx
|
51.99 | 0% | 0% | 3,739.11 | 0% | 0% |
|
NasdaqGS:CBAY
CymaBay Therapeutics
|
32.44 | 0% | 0% | 3,696.08 | 0% | 0% |
|
NasdaqGS:ARWR
Arrowhead Pharmaceuticals
|
22.53 | 0% | 0% | 3,663.63 | 0% | 0% |
|
NasdaqCM:VKTX
Viking Therapeutics
|
66.47 | 0% | 0% | 3,200.55 | 0% | 0% |
|
NasdaqGM:DRNA
Dicerna Pharmaceuticals
|
38.01 | 0% | 0% | 2,986.1 | 0% | 0% |
|
NasdaqCM:CLDX
Celldex Therapeutics
|
39.63 | 0% | 0% | 2,871.62 | 0% | 0% |
|
NasdaqGM:VCEL
Vericel
|
46.26 | -94.44% | -74.6% | 2,180.06 | 0% | 0% |
|
NasdaqGM:ARDX
Ardelyx
|
6.55 | 0% | 0% | 2,173.29 | 0% | 0% |
